The research was co-led by David Momtaz, a fourth-year medical student at the Long School of Medicine at UT Health San Antonio, and Daniel Pereira ...
News
- Patients Taking Semaglutide See Benefit After Total Hip Replacement - BioSpace
- Two Texas transplant programs team up to save lives | University Health
That's because University Health Transplant Institute in San Antonio and UT Southwestern Medical Center's Solid Organ Transplant Program in Dallas ...
- Greenwich LifeSciences Provides Update on Phase III Clinical Trial, Flamingo-01
Dec 5 - 9, 2023 – 2023 San Antonio Breast Cancer Symposium (SABCS); Nov 6 - 8, 2023 – BIO-Europe Fall 2023; Oct 20 - 22, 2023 – European Society for ...
- Infinity Pharmaceuticals Inc at 2021 San Antonio Breast Cancer S - GuruFocus
... Biotechnology INFIQ. Infinity Pharmaceuticals Inc at 2021 San Antonio Breast Cancer Symposium - Conference Call Transcript. Author's Avatar.
- Pasithea Therapeutics Announces Opening of Enrollment in the U.S. for its Phase 1 Trial of PAS-004
... biotechnology company developing PAS-004, a next ... Ildefonso Rodriguez M.D., acting as principal investigator for the San Antonio, TX site.